insights_inv_header

Investor insights

Investment resources primary

2020 YEAR-END & 2021 QUARTERLY OUTLOOK

Progressing toward a post-COVID-19 environment

As we say goodbye to a challenging 2020, we look out with optimism at the economic growth potential in the years to come. Can we expect the economic recovery to mirror that of the most recent Great Recession? Or, is more promising news ahead in a post-vaccine world?

2021 economic & financial markets outlook

2020 wrap-up

 
 

Election implication series

Economy & financial markets

Pre-election

Post-election

Tax and income planning

The views expressed in this series reflect the assessments of the applicable professionals based on current market conditions and other circumstances and do not necessarily reflect the views of CIBC Private Wealth Management. The views expressed here are for informational purposes only and are not intended to endorse, recommend, or favor either political party or any particular agenda.

 

Expert Q&A series

Legacy of COVID-19

Key innovations that emerged during this pandemic will outlive it. Others are yet to reveal themselves but will surely be part of the legacy of COVID-19. CIBC Private Wealth is committed to bringing to you the perspective and insight of top thinkers in various fields on what the legacy of COVID-19 could be.

 

Perspective

Ushering in the clean energy transition

2019 marked the first year in the modern electric era that renewable energy surpassed coal in the U.S. energy supply mix. This and other reasons lead to an attractive investment opportunity for companies delivering on the clean energy promise today.

Read more

 

2020 Quarterly Outlook

The markets recover. Will it last?

 

POST-PANDEMIC SERIES

Adapting to a changed landscape

Our investment professionals highlight the key economic and market changes that we believe will likely occur in the aftermath of the COVID-19 recession. 

 

June 2020

Our healthcare analysts discuss the rapidly evolving landscape around the creation of a coronavirus vaccine and the possible development and investment implications.
 

 

View previous investment insights